Ebr Systems, INC

EBR Systems, Inc. has successfully completed a A$150 million capital raise through a combination of an institutional placement and entitlement offer to fund expansion and development.

EBR Systems stockholders approved all director elections and equity incentive plan proposals at the 2026 annual meeting.

EBR Systems, Inc. has implemented a one-for-ten reverse stock split for its common stock, effective April 1, 2026.

EBR Systems, Inc. stockholders approved a reverse stock split and ratified the issuance of 55.9 million CDIs at a Special Meeting held on March 11, 2026.

EBR Systems announced significant commercial and clinical advancements in Q4 2025, including doubled case volumes and positive preliminary revenue estimates.

EBR Systems, Inc. successfully completed an institutional placement on the Australian Securities Exchange, raising approximately U.S. $36.0 million before fees, through the issuance of 55.9 million CDIs at A$1.00 each.

EBR Systems, Inc. reported increased net sales for Q2 2026, but also disclosed substantial doubt about its ability to continue as a going concern, despite FDA approval of its WiSE CRT System.

EBR Systems, Inc. reported its first quarter 2026 financial results, generating $2.4 million in revenue but facing substantial doubt about its ability to continue as a going concern.

EBR Systems, Inc. reported an increased net loss for the third quarter and first nine months of 2025 despite commencing commercial sales of its FDA-approved WiSE CRT System and securing significant capital.

EBR Systems reports its WiSE CRT System received FDA approval, leading to initial commercial revenue and a significant capital raise, extending its financial runway into 2027.

EBR Systems announces FDA approval for its WiSE CRT System and reports a net loss of $10.6 million for Q1 2025.

EBR Systems, a medical device company, announced its Q3 2024 financial results, highlighting ongoing development of its WiSE CRT System and a recent capital raise.

EBR Systems files its 10-K report, highlighting progress towards potential U.S. commercial launch of the WiSE CRT System in 2025, contingent on FDA approval.

Allan R Will, a Director of EBR Systems, Inc., received 42,106 shares of common stock on May 6, 2026.

David Steinhaus, a Director of EBR Systems, Inc., received 34,211 shares of common stock on May 6, 2026.

Christopher Nave, a Director of EBR Systems, Inc., received 34,211 shares of common stock on May 6, 2026.

Trevor J Moody, a Director of EBR Systems, Inc., received 34,211 shares of common stock on May 6, 2026.

John Mccutcheon, President and CEO and a Director of EBR Systems, Inc., received 188,462 shares of common stock on May 6, 2026.

Bronwyn Evans, a Director of EBR Systems, Inc., received 34,211 shares of common stock on May 6, 2026.

EBR Systems, Inc. is holding a special meeting on August 18-19, 2026, to seek stockholder approval for two significant issuances of CHESS Depositary Interests (CDIs) totaling over 169 million, priced at A$0.38 each.

EBR Systems, Inc. will hold its 2026 Annual Meeting to vote on director re-elections, a significant expansion of its equity incentive plan, and substantial option grants to executives and directors.

EBR Systems, Inc. has called a Special Stockholder Meeting to vote on a proposed reverse stock split and to ratify a significant issuance of CHESS Depositary Interests.

EBR Systems, Inc. calls a Special Meeting to approve a reverse stock split, ratify a A$75.9 million capital raise, and potentially adjourn the meeting.

EBR Systems, Inc. will hold its annual stockholders' meeting virtually on May 22, 2025, to vote on director elections, ratification of prior share issuance, equity incentive plan approvals, and an amendment to the Certificate of Incorporation.

EBR Systems is holding its 2025 Annual Meeting of Stockholders to vote on key proposals including director elections, amendments to the equity incentive plan, and limiting officer liability.

Split Rock Partners and associated entities have filed a Schedule 13G, reporting beneficial ownership of 2,937,570 shares of EBR Systems, Inc. common stock, representing 3.9% of the outstanding shares.

Several Carnegie-affiliated entities and Mark H. Carnegie have updated their beneficial ownership filings for EBR Systems, Inc., reporting a combined 6.3% stake as of June 30, 2026.

H.E.S.T. Australia Ltd. has reported beneficial ownership of 5.3% of EBR Systems, Inc. common stock, following a recent reverse stock split.

Host-Plus Pty Ltd, as trustee for the HOSTPLUS Pooled Superannuation Trust, has increased its beneficial ownership in EBR Systems, Inc. to 10.6% following a retail entitlement offer.

Regal Partners Funds Management Pty Limited and Regal Partners Limited have reported beneficial ownership of 11.62% of EBR Systems, Inc.'s ordinary shares.

H.E.S.T. Australia Ltd. has increased its beneficial ownership in EBR Systems, Inc. to 8.5% of common stock, totaling over 36.5 million shares.